Variant report
| Variant | nsv613334 |
|---|---|
| Chromosome Location | chr9:9800546-9819028 |
| allele | n/a |
| Outlinks | Ensembl UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
(count:2 , 50 per page) page:
1
| No. | lncRNA name | Chromosome Location | lncRNA alias |
|---|---|---|---|
| 1 | lnc-KDM4C-10 | chr9:9803717-9803784 | ENSG00000230920 |
| 2 | lnc-KDM4C-10 | chr9:9800546-9800674 | ENSG00000230920 |
| No data |
| No data |
| No data |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs1768881 | chr9:9800546-9800547 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 2 | rs532039177 | chr9:9800555-9800556 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
| 3 | rs1768880 | chr9:9800562-9800563 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 4 | rs190982779 | chr9:9800563-9800564 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
| 5 | rs535883273 | chr9:9800567-9800568 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
| 6 | rs3736873 | chr9:9800573-9800574 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
| 7 | rs566590767 | chr9:9800603-9800604 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
| 8 | rs41302055 | chr9:9800609-9800610 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
| 9 | rs558733063 | chr9:9800610-9800611 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
| 10 | rs1746799 | chr9:9800624-9800625 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 11 | rs138048235 | chr9:9800715-9800716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs540516834 | chr9:9800740-9800741 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs116555325 | chr9:9800747-9800748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs574879419 | chr9:9800752-9800753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs113552396 | chr9:9800757-9800758 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs560170133 | chr9:9800759-9800760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs116820561 | chr9:9800765-9800766 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs576893808 | chr9:9800781-9800782 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs543799732 | chr9:9800789-9800790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs377249909 | chr9:9800807-9800808 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs149372307 | chr9:9800846-9800847 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs545867733 | chr9:9800847-9800848 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs13283867 | chr9:9800854-9800855 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs548463729 | chr9:9800913-9800914 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs532123299 | chr9:9800929-9800930 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs4742621 | chr9:9800931-9800932 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 27 | rs546211521 | chr9:9800938-9800939 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs186540696 | chr9:9800944-9800945 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs73396844 | chr9:9801016-9801017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs77217984 | chr9:9801040-9801041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 31 | rs569033658 | chr9:9801079-9801080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs568874273 | chr9:9801116-9801117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs375329247 | chr9:9801127-9801128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs148085944 | chr9:9801144-9801145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs1323802 | chr9:9801153-9801154 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 36 | rs568383694 | chr9:9801163-9801164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs191197858 | chr9:9801170-9801171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs112310208 | chr9:9801182-9801183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs367633283 | chr9:9801208-9801209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs182891673 | chr9:9801209-9801210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs552909653 | chr9:9801244-9801245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs73396849 | chr9:9801281-9801282 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 43 | rs75359144 | chr9:9801308-9801309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs187589069 | chr9:9801326-9801327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs201427301 | chr9:9801328-9801329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs200182011 | chr9:9801338-9801339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs398087136 | chr9:9801348-9801349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs576213683 | chr9:9801349-9801350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs141841289 | chr9:9801360-9801361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 50 | rs192269246 | chr9:9801386-9801387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Variant related diseases (count:112)
| Disease | PMID | Source |
|---|---|---|
| abnormal development | 18461090 | CNVD |
| Disorders of sex development | 21048976 | CNVD |
| Honadal dysgenesis | 21048976 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Lung cancer | 16740712 | CNVD |
| Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
| Basal cell lymphoma | 17170743 | CNVD |
| Follicular lymphoma | 17170743 | CNVD |
| Oral squamous cell carcinoma | 17134496 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Hodgkin''s lymphoma | 18641027 | CNVD |
| Acute lymphoblastic leukemia | 20067559 | CNVD |
| Breast cancer | 16272173 | CNVD |
| Hepatocellular carcinoma | 16750200 | CNVD |
| Breast cancer | 17133270 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Cervical cancer | 21063398 | CNVD |
| Retinoblastoma | 22278416 | CNVD |
| Splenic marginal zone lymphoma | 18492102 | CNVD |
| Melanoma | 18172304 | CNVD |
| Biliary cancer | 19435499 | CNVD |
| Gastric cancer | 21586687 | CNVD |
| Esophageal squamous carcinoma | 18350619 | CNVD |
| Myopathy | 18421352 | CNVD |
| Neuroblastoma | 18664255 | CNVD |
| Acute lymphoblastic leukemia | 18957548 | CNVD |
| Myeloproliferative neoplasm | 17564968 | CNVD |
| Malignant meningioma | 17937814 | CNVD |
| Glioma | 21971842 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Hepatocellular carcinoma | 22174799 | CNVD |
| Oligodendroglial tumors | 17285580 | CNVD |
| Cutaneous squamous cell carcinomas | 19131950 | CNVD |
| Small bowel adenocarcinoma | 21586687 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Chordoma | 18071362 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Chordoma | 21602918 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Developmental delay | 19490664 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| microdeletion syndrome | 16199537 | CNVD |
| Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
| Cancer | 20164919 | CNVD |
| Chronic myeloid leukemia | 21384125 | CNVD |
| Ovarian cancer | 21720365 | CNVD |
| Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Lung cancer | 18438408 | CNVD |
| XY gonadal dysgenesis | 20685758 | CNVD |
| Urothelial carcinoma | 21177765 | CNVD |
| Oral cancer | 21386901 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Acute lymphoblastic leukemia | 21339820 | CNVD |
| Intellectual disability | 22102821 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Esophageal adenocarcinoma | 19417022 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Renal cell carcinoma | 21668985 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| Autism | 22495311 | CNVD |
| Hepatocellular carcinoma | 18803288 | CNVD |
| Breast cancer | 21364760 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Glioblastoma | 19074898 | CNVD |
| Malignant melanoma | 19074898 | CNVD |
| Prostate cancer | 16573809 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Ovarian clear cell carcinoma | 21343371 | CNVD |
| Cancer | 20164920 | CNVD |
| Lung cancer | 20668451 | CNVD |
| Schizophrenia | 20838587 | CNVD |
| Glioblastoma | 18772890 | CNVD |
| Glioblastoma multiforme | 21390271 | CNVD |
| Breast cancer | 20668451 | CNVD |
| Cancer | 20668451 | CNVD |
| Ovarian cancer | 20668451 | CNVD |
| Pancreas cancer | 20668451 | CNVD |
| Prostate cancer | 20668451 | CNVD |
| Autism | 20858261 | CNVD |
| Epilepsy | 20858261 | CNVD |
| Mental retardation | 20858261 | CNVD |
| Developmental delay | 21147756 | CNVD |
| small cell lung cancer | 21764851 | CNVD |
| Glioblastoma multiforme | 22286061 | CNVD |
| Glioma | 17123091 | CNVD |
| Lung cancer | 16773561 | CNVD |
| Colorectal cancer | 16272173 | CNVD |
| Esophageal squamous carcinoma | 18405350 | CNVD |
| Gastric cancer | 16891809 | CNVD |
| Mental retardation | 17847001 | CNVD |
| Cutaneous squamous cell carcinomas | 17420988 | CNVD |
| Acute lymphoblastic leukemia | 21390130 | CNVD |
| Pilocytic astrocytoma | 18670637 | CNVD |
| Acute lymphoblastic leukemia | 17690704 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Lung adenocarcinoma | 17982442 | CNVD |
| Breast cancer | 21611746 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr9:9799400-9800800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
| 2 | chr9:9799400-9801400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
| 3 | chr9:9799800-9800600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
| 4 | chr9:9799800-9800800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
| 5 | chr9:9799800-9801000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
| 6 | chr9:9800600-9801600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
| 7 | chr9:9800800-9801600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
| 8 | chr9:9801000-9801600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
| 9 | chr9:9805200-9806000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
| 10 | chr9:9807800-9808000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
